Global Steering Committee

James E. Bradner, M.D.
President, Novartis Institutes for BioMedical Research (NIBR)

Jeffrey A. Engelman, M.D., Ph.D.
Head, Oncology Research, Novartis Institutes for BioMedical Research

Jeff Porter, Ph.D.
Head, Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research (NIBR)

Karin Briner, Ph.D.
Head, Global Discovery Chemistry, Novartis Institutes for BioMedical Research (NIBR)

Ricardo Dolmetsch, Ph.D.
Head, Neuroscience, Novartis Institutes for BioMedical Research (NIBR)